Session detail

Back to the session list

Session type
Friday, April 26th 2019
Session time
17h00 - 18h30
Free communications 3: Melanoma biomarkers, diagnostic
Véronique BATAILLE (United Kingdom)
Julie DELYON (France)
Caroline GAUDY (France)
Emmanuella GUENOVA (Switzerland)
17h00 - 17h07
FC22 - Clinical and dermoscopic features of thin nodular melanoma: a study of the international dermoscopy society
A. Lallas, D. Sgouros, A. Zarras, A. Kyrgidis, G. Argenziano, I. Zalaudek, M. Pizzichetta, A. Marghoob, K. Liopyris, J. Malvehy, C. Oikonomou, R. Braun, A. Flórez Menedez, H. Cabo, G. Nazzaro, S. Lanssens, S. Menzies, J. Paoli, G. Kaminska-Winciorek, C. Longo, A. Katoulis, Z. Apalla, D. Ioannides, L. Thomas, I. Tromme, D. Ogata, C. Dessinioti, S. Puig, A. Scope, H. Kittler, A. J. Stratigos
17h07 - 17h14
FC23 - Computer-aided classifier with a deep convolutional neural network surpasses board-certified dermatologists in skin tumor diagnosis
Yasuhiro Fujisawa, Yuzo Otomo, Yasunari Ogata, Yoshiyuki Nakamura, Manabu Fujimoto (Japan)
17h14 - 17h21
FC20 - MC1R gene variants and melanoma risk according to histological type, body site, and breslow thickness: a pooled analysis from the M-SKIP project
Saverio Caini, Sara Gandini, Francesca Botta, Elena Tagliabue, Sara Raimondi, Eduardo Nagore, Ines Zanna, Patrick Maisonneuve, Julia Newton-Bishop, David Polsky, Rajiv Kumar, Peter A Kanetsky, Veronica Hoiom, Paola Ghiorzo, Maria Teresa Landi, Gloria Ribas, Chiara Menin, Alexander J Stratigos, Giuseppe Palmieri, Gabriella Guida, Jose Carlos García-Borrón, Hongmei Nan, Julian Little, Francesco Sera, Susana Puig, Maria Concetta Fargnoli (Italy)
17h21 - 17h28
FC26 - Multiple primary cutaneous melanoma: incidence, time to subsequent melanomas, differences in staging and survival
Mary-Ann El Sharouni, Arjen Witkamp, Vigfús Sigurdsson, Paul van Diest (Netherlands)
17h28 - 17h35
FC24 - Sex differences in genetic modulation of melanoma-specific and disease-free survival
Miriam Potrony, Neus Calbet-Llopart, Marc Combalia, Gemma Tell-Marti, Joan Anton Puig-Butille, Alicia Barreiro, Sebastian Podlipnik, Cristina Carrera, Josep Malvehy, Susana Puig (Spain)
17h35 - 17h42
FC30 - Clinicopathological factors associated with mortality of thin (≤1.00mm) cutaneous melanoma
Magdalena Claeson, Peter Baade, Susan Brown, H Peter Soyer, B Mark Smithers, Adele C Green, David C Whiteman, Kiarash Khosrotehrani (Australia)
17h42 - 17h49
FC25 - Inhibition of EMMPRIN/VEGFR-2 interaction decreases malignant phenotype of melanoma models
Alexandra Landras, Coralie Reger De Moura, Aurelie Sadoux, Bruno Villoutreix, Juan Fernandez- Recio, Maxime Battistella, Celeste Lebbe, Samia Mourah (France)
17h49 - 17h56
FC27 - Circulating PD-L1 expressing cytotoxic T cells are correlated with a negative immune climate and are prognostic in melanoma
Annabel Meireson, Vibeke Kruse, Inès Chevolet, Nora Sundahl, Piet Ost, Lieve Brochez (Belgium)
17h56 - 18h03
FC28 - Ambra1 and loricrin; a paradigm shift in the prognostication and stratification of AJCC stage I melanoma
Penny Lovat, Rob Ellis, Diana Tang, Batoul Nasr, Ashleigh McConnell, Joy Allen, Alison Greenwood, Paul Barrett, Edward Carling, Graeme Watson, Stuart Horswell, Dalvir Bajwa, Marie Labus (United Kingdom)
18h03 - 18h10
FC29 - A targeted mRNA analysis predicts survival of metastatic melanoma patients under braf inhibitors
Baptiste Louveau, Julie Delyon, Coralie Reger De Moura, Maxime Battistella, Fanelie Jouenne, Aurelie Sadoux, Marie-Pierre Podgorniak, Oren Marco, Julie Caramel, Stephane Dalle, Nicolas Dumaz, Celeste Lebbe, Samia Mourah (France)

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Ok Read more